3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
83
Squamous Cell Carcinoma of Head and Neck
51
Carcinoma, Non-Small-Cell Lung
30
Head and Neck Neoplasms
29
Colonic Neoplasms
22
Neoplasm Metastasis
18
Neoplasms
16
Rectal Neoplasms
14
Pancreatic Neoplasms
10
Lung Neoplasms
10
Mouth Neoplasms
8
Carcinoma, Squamous Cell
8
Laryngeal Neoplasms
7
Hypopharyngeal Neoplasms
7
Oropharyngeal Neoplasms
6
Carcinoma
6
Solid Tumors
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Gastrointestinal Neoplasms
5
Breast Neoplasms
5
Tongue Neoplasms
4
Ovarian Neoplasms
4
Endometrial Neoplasms
4
Thyroid Neoplasms
3
Recurrence
3
Melanoma
3
Digestive System Neoplasms
3
Colorectal Cancer Metastatic
3
Carcinoma, Renal Cell
3
Carcinoma, Pancreatic Ductal
3
Interventions
pembrolizumab
1
nazartinib
1
Waiting Lists
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Noonan Syndrome
×
Cetuximab
×
1 year
×
Clear all
NCT04670679
2026-03-25
FLAGSHP-1
Erasca, Inc.
Phase 1
Active not recruiting
90 enrolled